#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Vaginal cancer Adenocarcinoma pancreas Myotonia Ocular myasthenia Waldenstrom's macroglobulinaemia Still's disease Acute myeloid leukaemia refractory Hepatobiliary cancer Candida infection Epstein-Barr virus infection Neonatal alloimmune thrombocytopenia Eosinophilic oesophagitis Pleomorphic liposarcoma Scedosporium infection Adenovirus infection More trials…

    Learn about Rare Diseases

    Primary biliary cholangitis – Treatment Myelodysplastic syndrome with excess blasts – Diagnostics Marfan’s syndrome – Life with Disease Mantle cell lymphoma stage IV – Treatment Turner’s syndrome – Trials in Disease Haemophilia A with anti factor VIII – Basic Information Fabry’s disease Glycogen storage disease type I – Basic Information Wolfram syndrome – Basic Information Primary immunodeficiency syndrome – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    IMEROPRUBART Hydroxypropyl Cellulose Lf Antithrombin Iii Human Imlifidase Mps-216 Irbesartan AGALSIDASE BETA Potassium Canrenoate Kbp-336 Casirivimab Mezigdomide Marstacimab Temsirolimus Copper (64Cu) Chloride Soya-Bean Oil Refined Urokinase Floxuridine Isotretinoin Tucatinib Fluorouracil More therapies…

    Learn about Your Condition

    Endocrine disorder Cholangiosarcoma Primary hyperoxaluria Shprintzen-Goldberg syndrome Cortisol abnormal Endotracheal intubation Hepatic cirrhosis Nodal osteoarthritis Chondrocalcinosis Erdheim-Chester disease Paraesthesia Hypogonadism male Penile cancer Renal cell carcinoma Somatic symptom disorder More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • Study on Stopping Nilotinib for Chronic Myeloid Leukemia Patients After Previous Unsuccessful Attempts to Stop Tyrosine Kinase Inhibitors

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Chronic myeloid leukaemia (in remission)
    Investigated Drugs:
    • Nilotinib
    Germany

  • Study on Treating Smoldering and Active Multiple Myeloma with Dexamethasone, Lenalidomide, and Carfilzomib for Patients in Iceland

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Plasma cell myeloma
    Investigated Drugs:
    • Carfilzomib
    • Dexamethasone
    • Lenalidomide
    Iceland

  • Study on Allogeneic Faecal Microbiota for Treating Antibiotic-Related Diarrhea in Critically Ill Patients

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Diarrhoea
    Investigated Drugs:
    • Allogeneic Faecal Microbiota, Pooled
    Czechia

  • Study on Alectinib for Patients with ALK+ Stage III Non-Small Cell Lung Cancer

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer stage III
    Investigated Drugs:
    • Alectinib
    Italy

  • Study on Treosulfan and Melphalan for High-Risk Ewing Sarcoma Patients

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Ewing’s sarcoma
    Investigated Drugs:
    • Treosulfan
    • Cyclophosphamide
    • Doxorubicin Hydrochloride
    Italy

  • Study of [18F]MC225 to Assess P-glycoprotein Function in Patients with Alzheimer’s, Mild Cognitive Impairment, and Parkinson’s Disease

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Cerebral amyloid angiopathy
    • Parkinson’s disease
    • Dementia Alzheimer’s type
    Investigated Drugs:
    • [18F]Mc225
    The Netherlands
Previous Page
1 … 840 841 842 843 844 … 1,673
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!